Understanding gene-environment interactions leads to possible preventive treatment
An inhaled form of a high blood pressure medication has potential to treat certain types of anxiety as well as pain, according to a new study by the Centre for Addiction and Mental Health (CAMH).
Anxiety disorders are usually treated with different types of medications, such as antidepressants, and psychotherapy. Amiloride is a medication offering a new approach, as a short-acting nasal spray that could be used to prevent an anxiety attack.
“Inhaled amiloride may prove to have benefits for panic disorder, which is typically characterized by spells of shortness of breath and fear, when people feel anxiety levels rising,” says lead author Dr. Marco Battaglia, Associate Chief of Child and Youth Psychiatry and Clinician Scientist in the Campbell Family Mental Health Research Institute at CAMH.
The study was based on understanding the key physiological changes in brain functioning that are linked to anxiety and pain sensitivity. The researchers then tested a molecule, amiloride, which targets this functioning.
Amiloride was inhaled so that it could immediately access the brain. The study showed that it reduced the physical respiratory signs of anxiety and pain in a preclinical model of illness. This therapeutic effect didn’t occur when amiloride was administered in the body, as it didn’t cross the blood-brain barrier and did not reach the brain.
Results were published in the Journal of Psychopharmacology.
The role of early life adversity
The study is based on years of research into how a person’s early life experiences affect their genes, says Dr. Battaglia. Childhood adversity, such as loss or separation from parents, increases the risk of anxiety disorders and pain, among other health issues.
At a molecular level, these negative life experiences are linked to changes in some genes of the ASIC (acid-sensing-ion-channels) family. While the DNA itself doesn’t change, the way it functions is affected.
DNA is converted into working proteins through a process called gene expression. As a result of childhood adversity, some ASIC genes showed increased expression and epigenomic changes. (“Epigenomic” refers to changes in gene regulation that can inherited by children). Overlapping genetic changes were also seen in blood taken from twins who responded to specific tests designed to provoke panic.
These genetic changes are linked to physical symptoms. Breathing can be affected, due to over-sensitivity to higher carbon dioxide levels in the air. In such situations, a person might hyperventilate and experience growing anxiety. Preclinical and human data are strikingly similar in this regard. “As a treatment, amiloride turned out to be very effective preclinically,” says Dr. Battaglia.
The next step in his research is to test whether it eases anxiety symptoms. Dr. Battaglia is now launching a pilot clinical trial, supported through a seed grant from CAMH’s new Discovery Fund. Collaborators at the University of Utah are testing the drug’s safety.
Amiloride has been used as an oral treatment for decades for hypertension, and as an inhaled spray in a few experimental studies of cystic fibrosis, he notes. The researchers are therefore further ahead than if they had to develop and test an entirely new medication.
The Latest on: Amiloride
via Google News
The Latest on: Amiloride
- Amiloride and Hydrochlorothiazideon October 9, 2019 at 5:00 pm
This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.
- Salt taste transduction occurs through an amiloride-sensitive sodium transport pathwayon September 8, 2019 at 9:21 pm
The inward current caused by sodium chloride placed on the mucosal surface of an in vitro preparation of rat dorsal lingual epithelium can be substantially reduced by the blocker of sodium ion ...
- Therapeutic potential of analogues of amiloride: inhibition of the regulation of intracellular pH as a possible mechanism of tumour selective therapyon March 24, 2019 at 9:43 pm
Amiloride and its analogues DMA (5-(N,N-dimethyl)amiloride), MIBA (5-(N-methyl-N-isobutyl)amiloride) and EIPA (5-(N-ethyl-N-isopropyl)amiloride) are known to inhibit the Na+/H+ antiport and therefore ...
- Amiloride and Hydrochlorothiazide - Indications, Dosage, Side Effects and Precautionson January 1, 2019 at 4:00 pm
• Caution should be exercised in patients with history of untreated salt/mineral imbalance (such as high potassium, low sodium level), kidney disease, liver disease, diabetes, loss of water content in ...
- Amiloride-Hydrochlorothiazideon November 8, 2018 at 4:00 pm
Amiloride is a potassium sparing-diuretic that also prevents your body from absorbing too much salt and keeps your potassium levels from getting too low. The combination of hydrochlorothiazide and ...
- Fluoxetine, Riluzole or Amiloride No Benefit in Progressive MSon October 23, 2018 at 4:46 am
BERLIN — The first-ever multiarm phase 2 trial of different interventions for secondary progressive multiple sclerosis (MS) has shown no therapeutic benefit of any of the three drugs tested — ...
- Inhaled blood pressure drug could prevent panic attackson September 14, 2018 at 12:09 am
Amiloride, a drug that's used to treat hypertension, successfully relieves signs of anxiety and panic in a preclinical study. The findings are underpinned and strengthened by epigenetic changes caused ...
- Amiloride and the diabetic kidneyon May 8, 2018 at 5:00 pm
Tel: +1 336 716 9236; fax: +1 336 716 2456; e-mail: [email protected] The present study demonstrates a significant effect of amiloride to reduce BP and stimulate sodium excretion in type 1 ...
- DETANONOate, a Nitric Oxide Donor, Decreases Amiloride-sensitive Alveolar Fluid Clearance in Rabbitson May 6, 2018 at 5:08 am
While DETANONOate administration over a 30-fold dose range did not decrease total AFC, the amiloride-sensitive fraction of AFC was decreased. This decrease in the amiloride-sensitive fraction of AFC ...
- Amelioration of Polyuria by Amiloride in Patients Receiving Long-Term Lithium Therapyon May 6, 2018 at 12:48 am
We studied the effect of amiloride on lithium-induced polyuria in nine such patients receiving maintenance lithium therapy who had a vasopressin-resistant defect in urinary concentrating ability.
via Bing News